Last updated on November 2019

PENTHROX in the Canadian Emergency Department (ED)


Brief description of study

This Canadian, multi-centre, prospective, real world study is designed to evaluate the effectiveness of low dose methoxyflurane (MEOF) (PENTHROX) for the treatment of moderate to severe pain associated with trauma in the Canadian ED.

Detailed Study Description

The study will assess the change in pain intensity over 20 minutes from start of administration of PENTHROX and will generate Real World Evidence in support of existing clinical trial data including effectiveness, safety and additional parameters of low dose MEOF (PENTHROX) in Canadian EDs.

Clinical Study Identifier: NCT03868436

Find a site near you

Start Over